Bristol Myers (Brazil) Performance
| BMYB34 Stock | BRL 341.31 0.39 0.11% |
On a scale of 0 to 100, Bristol Myers holds a performance score of 17. The firm shows a Beta (market volatility) of 0.1, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Bristol Myers' returns are expected to increase less than the market. However, during the bear market, the loss of holding Bristol Myers is expected to be smaller as well. Please check Bristol Myers' downside deviation, standard deviation, total risk alpha, as well as the relationship between the coefficient of variation and jensen alpha , to make a quick decision on whether Bristol Myers' price patterns will revert.
Risk-Adjusted Performance
17 of 100
Weak | Strong |
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Bristol Myers Squibb are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Bristol Myers sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 14.3 B |
Bristol |
Bristol Myers Relative Risk vs. Return Landscape
If you would invest 26,433 in Bristol Myers Squibb on August 28, 2024 and sell it today you would earn a total of 7,698 from holding Bristol Myers Squibb or generate 29.12% return on investment over 90 days. Bristol Myers Squibb is generating 0.4316% of daily returns and assumes 1.9752% volatility on return distribution over the 90 days horizon. Simply put, 17% of stocks are less volatile than Bristol, and 92% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Bristol Myers Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Bristol Myers' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Bristol Myers Squibb, and traders can use it to determine the average amount a Bristol Myers' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.2185
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | BMYB34 | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.98 actual daily | 17 83% of assets are more volatile |
Expected Return
| 0.43 actual daily | 8 92% of assets have higher returns |
Risk-Adjusted Return
| 0.22 actual daily | 17 83% of assets perform better |
Based on monthly moving average Bristol Myers is performing at about 17% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Bristol Myers by adding it to a well-diversified portfolio.
Bristol Myers Fundamentals Growth
Bristol Stock prices reflect investors' perceptions of the future prospects and financial health of Bristol Myers, and Bristol Myers fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Bristol Stock performance.
| Return On Equity | 0.18 | |||
| Return On Asset | 0.0613 | |||
| Profit Margin | 0.14 % | |||
| Operating Margin | 0.20 % | |||
| Current Valuation | 1.04 T | |||
| Shares Outstanding | 2.13 B | |||
| Price To Earning | 50.79 X | |||
| Price To Book | 5.00 X | |||
| Price To Sales | 18.62 X | |||
| Revenue | 46.16 B | |||
| EBITDA | 18.54 B | |||
| Cash And Equivalents | 29.36 B | |||
| Cash Per Share | 17.95 X | |||
| Total Debt | 39.6 B | |||
| Debt To Equity | 159.70 % | |||
| Book Value Per Share | 15.38 X | |||
| Cash Flow From Operations | 16.21 B | |||
| Earnings Per Share | 15.61 X | |||
| Total Asset | 109.31 B | |||
About Bristol Myers Performance
By analyzing Bristol Myers' fundamental ratios, stakeholders can gain valuable insights into Bristol Myers' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Bristol Myers has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Bristol Myers has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in New York, New York. BRISTOLMYERSDRN operates under Drug Manufacturers - Major classification in Brazil and is traded on Sao Paolo Stock Exchange. It employs 23300 people.Things to note about Bristol Myers Squibb performance evaluation
Checking the ongoing alerts about Bristol Myers for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Bristol Myers Squibb help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Bristol Myers Squibb has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations |
- Analyzing Bristol Myers' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Bristol Myers' stock is overvalued or undervalued compared to its peers.
- Examining Bristol Myers' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Bristol Myers' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Bristol Myers' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Bristol Myers' stock. These opinions can provide insight into Bristol Myers' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Bristol Stock analysis
When running Bristol Myers' price analysis, check to measure Bristol Myers' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bristol Myers is operating at the current time. Most of Bristol Myers' value examination focuses on studying past and present price action to predict the probability of Bristol Myers' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bristol Myers' price. Additionally, you may evaluate how the addition of Bristol Myers to your portfolios can decrease your overall portfolio volatility.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |